» Articles » PMID: 35242361

Limited Genomic Reconstruction of SARS-CoV-2 Transmission History Within Local Epidemiological Clusters

Abstract

A detailed understanding of how and when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission occurs is crucial for designing effective prevention measures. Other than contact tracing, genome sequencing provides information to help infer who infected whom. However, the effectiveness of the genomic approach in this context depends on both (high enough) mutation and (low enough) transmission rates. Today, the level of resolution that we can obtain when describing SARS-CoV-2 outbreaks using just genomic information alone remains unclear. In order to answer this question, we sequenced forty-nine SARS-CoV-2 patient samples from ten local clusters in NW Spain for which partial epidemiological information was available and inferred transmission history using genomic variants. Importantly, we obtained high-quality genomic data, sequencing each sample twice and using unique barcodes to exclude cross-sample contamination. Phylogenetic and cluster analyses showed that consensus genomes were generally sufficient to discriminate among independent transmission clusters. However, levels of intrahost variation were low, which prevented in most cases the unambiguous identification of direct transmission events. After filtering out recurrent variants across clusters, the genomic data were generally compatible with the epidemiological information but did not support specific transmission events over possible alternatives. We estimated the effective transmission bottleneck size to be one to two viral particles for sample pairs whose donor-recipient relationship was likely. Our analyses suggest that intrahost genomic variation in SARS-CoV-2 might be generally limited and that homoplasy and recurrent errors complicate identifying shared intrahost variants. Reliable reconstruction of direct SARS-CoV-2 transmission based solely on genomic data seems hindered by a slow mutation rate, potential convergent events, and technical artifacts. Detailed contact tracing seems essential in most cases to study SARS-CoV-2 transmission at high resolution.

Citing Articles

Comprehensive contact tracing during an outbreak of alpha-variant SARS-CoV-2 in a rural community reveals less viral genomic diversity and higher household secondary attack rates than expected.

Sivertsen A, Mortensen N, Solem U, Valen E, Bullita M, Wensaas K mSphere. 2024; 9(8):e0011424.

PMID: 39109863 PMC: 11351100. DOI: 10.1128/msphere.00114-24.


Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern.

Davina-Nunez C, Perez S, Cabrera-Alvargonzalez J, Rincon-Quintero A, Treinta-Alvarez A, Godoy-Diz M PLoS One. 2024; 19(4):e0289188.

PMID: 38683803 PMC: 11057745. DOI: 10.1371/journal.pone.0289188.


Changing genomic epidemiology of COVID-19 in long-term care facilities during the 2020-2022 pandemic, Washington State.

Oltean H, Black A, Lunn S, Smith N, Templeton A, Bevers E BMC Public Health. 2024; 24(1):182.

PMID: 38225567 PMC: 10789038. DOI: 10.1186/s12889-023-17461-2.


A systematic review of the barcoding strategy that contributes to COVID-19 diagnostics at a population level.

Chen H Front Mol Biosci. 2023; 10:1141534.

PMID: 37496777 PMC: 10366608. DOI: 10.3389/fmolb.2023.1141534.


Enabling accurate and early detection of recently emerged SARS-CoV-2 variants of concern in wastewater.

Sapoval N, Liu Y, Lou E, Hopkins L, Ensor K, Schneider R Nat Commun. 2023; 14(1):2834.

PMID: 37198181 PMC: 10191095. DOI: 10.1038/s41467-023-38184-3.


References
1.
Seemann T, Lane C, Sherry N, Duchene S, Goncalves da Silva A, Caly L . Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020; 11(1):4376. PMC: 7462846. DOI: 10.1038/s41467-020-18314-x. View

2.
Valesano A, Rumfelt K, Dimcheff D, Blair C, Fitzsimmons W, Petrie J . Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. PLoS Pathog. 2021; 17(4):e1009499. PMC: 8055005. DOI: 10.1371/journal.ppat.1009499. View

3.
Koyama T, Platt D, Parida L . Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ. 2020; 98(7):495-504. PMC: 7375210. DOI: 10.2471/BLT.20.253591. View

4.
Quick J, Grubaugh N, Pullan S, Claro I, Smith A, Gangavarapu K . Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc. 2017; 12(6):1261-1276. PMC: 5902022. DOI: 10.1038/nprot.2017.066. View

5.
Graudenzi A, Maspero D, Angaroni F, Piazza R, Ramazzotti D . Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity. iScience. 2021; 24(2):102116. PMC: 7842190. DOI: 10.1016/j.isci.2021.102116. View